SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $244,000 | +10.9% | 938,388 | +2.3% | 0.00% | – |
| Q1 2016 | $220,000 | -48.7% | 917,690 | -24.8% | 0.00% | – |
| Q4 2015 | $429,000 | +6028.6% | 1,220,024 | +29269.9% | 0.00% | – |
| Q3 2015 | $7,000 | -92.0% | 4,154 | -89.4% | 0.00% | – |
| Q2 2015 | $87,000 | -78.8% | 39,135 | -81.5% | 0.00% | – |
| Q1 2015 | $411,000 | -25.5% | 211,974 | +1.8% | 0.00% | -100.0% |
| Q4 2014 | $552,000 | +334.6% | 208,257 | +394.4% | 0.00% | – |
| Q3 2014 | $127,000 | -49.0% | 42,126 | -30.9% | 0.00% | – |
| Q2 2014 | $249,000 | +1975.0% | 60,975 | +2071.5% | 0.00% | – |
| Q1 2014 | $12,000 | -98.6% | 2,808 | -98.2% | 0.00% | -100.0% |
| Q4 2013 | $833,000 | +260.6% | 159,082 | +335.1% | 0.00% | – |
| Q3 2013 | $231,000 | 0.0% | 36,565 | -21.1% | 0.00% | – |
| Q2 2013 | $231,000 | – | 46,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |